These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6529497)

  • 1. [Stability of parenteral formulations of apomorphine].
    Pandolfo V; Tanini R; Polidori G; Santoni G
    Boll Chim Farm; 1984 Sep; 123(9):449-52. PubMed ID: 6529497
    [No Abstract]   [Full Text] [Related]  

  • 2. Labile iron in parenteral iron formulations: a quantitative and comparative study.
    Coyne DW
    Nephrol Dial Transplant; 2004 Oct; 19(10):2674-5; author reply 2675-6. PubMed ID: 15388831
    [No Abstract]   [Full Text] [Related]  

  • 3. Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management.
    Antonini A; Tolosa E
    Expert Rev Neurother; 2009 Jun; 9(6):859-67. PubMed ID: 19496689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of parenteral midazolam in an oral formulation.
    Walker SE; Grad HA; Haas DA; Mayer A
    Anesth Prog; 1997; 44(1):17-22. PubMed ID: 9481976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apomorphine: a stable solution.
    Jaeger RW; de Castro FJ
    Clin Toxicol; 1976; 9(2):199-202. PubMed ID: 939074
    [No Abstract]   [Full Text] [Related]  

  • 6. Preformulation stability testing of parenteral products.
    Zoglio MA
    Bull Parenter Drug Assoc; 1968; 22(6):295-8. PubMed ID: 5727165
    [No Abstract]   [Full Text] [Related]  

  • 7. Apomorphine in dopaminergic therapy.
    Subramony JA
    Mol Pharm; 2006; 3(4):380-5. PubMed ID: 16889431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of apomorphine in Parkinson's disease.
    Gancher S
    J Neural Transm Suppl; 1995; 45():137-41. PubMed ID: 8748619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary study on the potential utility of GFP as a biosensor for drug stability in parenteral solutions.
    dos Santos CA; Mazzola PG; Silva PH; Cholewa O; Penna TC
    Biotechnol Prog; 2007; 23(4):979-84. PubMed ID: 17567040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Shifting to subcutaneous infusion of apomorphine in advanced Parkinson's disease patients on an out-patient basis: experience and recommendations].
    Castaño B; Mateo D; Giménez-Roldán S
    Neurologia; 2007 Apr; 22(3):133-7. PubMed ID: 17364250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
    Manson AJ; Turner K; Lees AJ
    Mov Disord; 2002 Nov; 17(6):1235-41. PubMed ID: 12465062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation and automation of a particle detection system for parenteral products.
    Knapp JZ; Kushner HK
    J Parenter Drug Assoc; 1980; 34(5):369-93. PubMed ID: 6905868
    [No Abstract]   [Full Text] [Related]  

  • 13. Stabilizers for parenteral drugs.
    Scheindlin S
    Bull Parenter Drug Assoc; 1966; 20(2):61-4. PubMed ID: 5905230
    [No Abstract]   [Full Text] [Related]  

  • 14. Stability of apomorphine in frozen plasma samples.
    Smith RV; Humphrey DW; Wilcox RE
    Res Commun Chem Pathol Pharmacol; 1980 Jan; 27(1):183-6. PubMed ID: 7360998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photostability of parenteral chemotheraphy admixtures.
    Siderov J; Stevenson B
    J Oncol Pharm Pract; 2007 Dec; 13(4):231. PubMed ID: 18045782
    [No Abstract]   [Full Text] [Related]  

  • 16. Apomorphine (Apokyn) for advanced Parkinson's Disease.
    Med Lett Drugs Ther; 2005 Jan; 47(1200):7-8. PubMed ID: 15647705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug data: intravenous admixtures.
    Mar DD
    Am J Nurs; 1981 Mar; 81(3):574-5. PubMed ID: 6906983
    [No Abstract]   [Full Text] [Related]  

  • 18. Penicillin instability in infusions.
    Br Med J; 1970 Dec; 4(5735):571. PubMed ID: 5485170
    [No Abstract]   [Full Text] [Related]  

  • 19. Stability of melphalan in infusion fluids.
    Tabibi SE; Cradock JC
    Am J Hosp Pharm; 1984 Jul; 41(7):1380-2. PubMed ID: 6465155
    [No Abstract]   [Full Text] [Related]  

  • 20. Compatibility and stability of clindamycin phosphate with intravenous fluids.
    Porter WR; Johnson CA; Cohon MS; Gillespie W
    Am J Hosp Pharm; 1983 Jan; 40(1):91-4. PubMed ID: 6823996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.